Bernard Doger
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 26
- Cancer Immunotherapy and Biomarkers 10
- Peptidase Inhibition and Analysis 5
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Víctor Moreno (21 shared papers)Emiliano Calvo (13 shared papers)Irene Braña (6 shared papers)Tatiana Hernández (3 shared papers)Martin David Forster (6 shared papers)Malaka Ameratunga (1 shared paper)Johann Sebastian De Bono (1 shared paper)Hui Kong Gan (1 shared paper)
- Journals
- Annals of Oncology (6 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)European Journal of Cancer (4 papers)Drugs of today (2 papers)Cancers (2 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Bernard Doger
43 papers receiving 1.2k citations
Bernard Doger's Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 612
- Cancer Research 208
- Pulmonary and Respiratory Medicine 323
- Radiology, Nuclear Medicine and Imaging 135
- Molecular Biology 382
Countries citing papers authored by Bernard Doger
This map shows the geographic impact of Bernard Doger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Doger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Doger more than expected).
Fields of papers citing papers by Bernard Doger
This network shows the impact of papers produced by Bernard Doger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Doger. The network helps show where Bernard Doger may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernard Doger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HER kinase inhibition in patients with HER2- and HER3-mutant cancers Hit paper breakdown → | 2018 | 620 |
| 2 | MYC targeting by OMO-103 in solid tumors: a phase 1 trial Hit paper breakdown → | 2024 | 125 |
| 3 | 2017 | 66 | |
| 4 | 2020 | 61 | |
| 5 | 2023 | 58 | |
| 6 | 2021 | 58 | |
| 7 | 2021 | 21 | |
| 8 | 2025 | 20 | |
| 9 | 2024 | 20 | |
| 10 | 2021 | 19 | |
| 11 | 2023 | 19 | |
| 12 | 2021 | 16 | |
| 13 | 2022 | 13 | |
| 14 | 2024 | 13 | |
| 15 | 2018 | 13 | |
| 16 | 2020 | 10 | |
| 17 | 2015 | 9 | |
| 18 | 2021 | 9 | |
| 19 | 2024 | 8 | |
| 20 | 2024 | 8 |
About Bernard Doger
Bernard Doger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (5 papers), Lung Cancer Treatments and Mutations (5 papers), Head and Neck Cancer Studies (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (612 citations), Cancer Research (208 citations), Pulmonary and Respiratory Medicine (323 citations), Radiology, Nuclear Medicine and Imaging (135 citations) and Molecular Biology (382 citations). Bernard Doger has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Víctor Moreno, Emiliano Calvo, Irene Braña, Tatiana Hernández, Martin David Forster, Malaka Ameratunga, Johann Sebastian De Bono, Hui Kong Gan, Alvaro Ingles Russo Garces and Caroline Hoffmann. Their work appears in journals such as Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer, Drugs of today and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.